Proteomic Based Drug Discovery Summit 2025
Evvnt Promotion / evvnt
Archiv
11.02.2025 - 13.02.2025 Wyndham Boston Beacon Hill, 5 Blossom Street, 02114 Boston, Massachusetts, USA
Time: 8:30 am to 4:30 pm
Kongressthemen
Proteomics offers huge advantages for the discovery and pre-clinical development of small molecule drugs and their translation into robust clinical candidates. Just this year, Sanofi has dedicated $700M to Belharra Therapeutics to develop a proteomics platform and Galapagos has partnered with Bridgene Bio to combine chemoproteomics with computational tools.
This is the time to harness the power of proteomics to accelerate your drug development process and de-risk your pipeline.
Proteomics offers huge advantages for the discovery and pre-clinical development of small molecule drugs and their translation into robust clinical candidates. Just this year, Sanofi has dedicated $700M to Belharra Therapeutics to develop a proteomics platform and Galapagos has partnered with Bridgene Bio to combine chemoproteomics with computational tools.
This is the time to harness the power of proteomics to accelerate your drug development process and de-risk your pipeline.
Wissenschaftliche Fach-Gesellschaft
Hanson Wade
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/2674449-3?pid=4832
Speakers: Alex Campos, Senior Director - Systems Biology and Proteomics, Plexium Inc., Bekim Bajrami, Associate Scientific Director, Biogen and more.
Brochure: https://go.evvnt.com/2674449-3?pid=4832
Speakers: Alex Campos, Senior Director - Systems Biology and Proteomics, Plexium Inc., Bekim Bajrami, Associate Scientific Director, Biogen and more.
Anfragen und Anmeldung:
https://go.evvnt.com/2674449-2?pid=4832
Frau Lucy Rutherford
Gesundheitsversorgung, Pharmakologie und Toxikologie
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
